A clinical and economic evaluation of Control of Hyperglycaemia in Paediatric intensive care (CHiP): a randomised controlled trial.
- Submitting institution
-
London School of Hygiene and Tropical Medicine
- Unit of assessment
- 2 - Public Health, Health Services and Primary Care
- Output identifier
- 382
- Type
- D - Journal article
- DOI
-
10.3310/hta18260
- Title of journal
- Health technology assessment (Winchester, England)
- Article number
- -
- First page
- 1
- Volume
- 18
- Issue
- 26
- ISSN
- 1366-5278
- Open access status
- Out of scope for open access requirements
- Month of publication
- -
- Year of publication
- 2014
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
22
- Research group(s)
-
-
- Citation count
- 10
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- Richard Grieve (Reader in Health Economics) led the health economic evaluation and was involved in the design and conduct of research, the trial development group, the project management group and the TSC, the statistical analysis, and the interpretation and reporting of results. He wrote the economic evaluation sections of the report and revised the manuscript for important intellectual content.
- Non-English
- No
- English abstract
- -
